Mitchell Lee

Strategic Advisor at Ora Biomedical, Inc.

Mitchell Lee has a diverse work experience that spans various roles and industries. Mitchell is currently the Chief Executive Officer at Ora Biomedical, Inc. and is responsible for leading the company. Prior to this, they worked as a CoMotion Commercialization Fellow at the University of Washington, where they focused on commercializing research findings. Mitchell also served as a Senior Fellow at the Promislow Lab, where they conducted research on the biology of aging.

Before their roles in academia, Mitchell was a PHD Student at the University of Washington - School of Medicine, studying the connection between cancer biology and aging. Mitchell also gained teaching experience as a TA/Lab instructor at the Marine Biological Laboratory, where they taught molecular biology of aging.

In addition, Mitchell has academic experience from Western Washington University, where they completed their Bachelor's degree and later pursued a Master's degree in Molecular Neurodevelopment. Mitchell also served as a TA/Lab Instructor at the university.

Outside of academia, Mitchell worked as a Desk Clerk at Baymont Inn & Suites and held various positions in the hospitality industry since they were 17. Mitchell started their work journey at the age of 10 as a stock/cleanup boy at a convenience store in rural Oklahoma.

Overall, Mitchell's work experience showcases a strong background in research, leadership, teaching, and customer service.

Mitchell Lee received their education from various institutions. In 2007 to 2010, they attended Western Washington University and obtained a Bachelor of Science degree in Biology. During the same period, they also earned a Bachelor of Arts degree in Philosophy from the same university. From 2010 to 2012, Mitchell pursued a Master of Science degree in Biology at Western Washington University. Mitchell continued their education at the University of Washington, where they obtained a Doctor of Philosophy degree in Pathology/Molecular Medicine from 2012 to 2018. In 2021 and 2022, Mitchell attended the University of Washington - Michael G. Foster School of Business and received a certificate in Biotechnology Project Management. In terms of additional certifications, Mitchell obtained a HHMI Molecular Medicine certification from the University of Washington - School of Medicine in April 2016. Additionally, they completed a Science Communication Fellowship at the Pacific Science Center in August 2015.

Location

Seattle, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Ora Biomedical, Inc.

Ora Biomedical, Inc. is a new pharmaceutical company launched out of the Kaeberlein Lab at the University of Washington. We built a high-throughput small molecule discovery platform to identify longevity interventions, including natural products, pharmaceuticals, and small molecule combinations at a previously unimagined scale. The foundation ofour platform is the WormBot-AI, a robotic system coupled with AI-powered analytics to perform phenotype-based screens in live animals. The WormBot-AI is robust, stable, scalable, and already in use identifying novel interventions and aging targets. Ora Biomedical holds the exclusive commercial use rights to the WormBot platform and AI software.


Industries

Employees

1-10

Links